YAP/TEAD Inhibitor VT3989 Shows Antitumor Activity in Mesothelioma and NF2-Mutant Cancers 3 min read Editor's Picks Lifestyle YAP/TEAD Inhibitor VT3989 Shows Antitumor Activity in Mesothelioma and NF2-Mutant Cancers April 16, 2023 YAP/TEAD Inhibitor VT3989 Shows Antitumor Activity in Mesothelioma and NF2-Mutant Cancers,The first-in-class YAP/TEAD inhibitor...Read More
